Arbutus Reports First Quarter 2025 Financial Results and Provides Corporate Update
Provided By GlobeNewswire
Last update: May 14, 2025
Imdusiran combination therapy has functionally cured 8 patients with chronic hepatitis B (cHBV) to date, including 2 patients who received no interferon
Read more at globenewswire.com4.43
-0.05 (-1.12%)
Find more stocks in the Stock Screener
ABUS Latest News and Analysis
2 days ago - By: Chartmill
